List of insiders holdings for Astria Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Xontogeny LLC Perceptive Xontogeny Venture Fund LP EDELMAN JOSEPH Director 10% Owner | 2024-11-14 16:41:28 | 6,485,420 0 | 6,485,420 | Form 13D |
| 2 | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive Xontogeny Venture Fund LP EDELMAN JOSEPH Director | 2024-11-14 16:41:28 | 6,485,420 0 | 6,485,420 | Form 13D |
| 3 | SVLSF V LLC SV Life Sciences Fund V (GP) LP SV LIFE SCIENCES FUND V LP SV Life Sciences Fund V Strategic Partners L.P. 10% Owner | 2017-02-07 06:11:32 | 2,857,667 0 | 2,857,667 | Form 13D |
| 4 | Clarus Lifesciences II L.P. Clarus Ventures II GP L.P. Clarus Ventures II LLC 10% Owner | 2018-04-04 16:42:28 | 2,024,783 0 | 2,024,783 | Form 13D |
| 5 | Laufer Ron Director 10% Owner | 2015-06-30 18:45:19 | 11,094 1,632,652 | 1,643,746 | Form 4 |
| 6 | MedImmune Ventures Inc. 10% Owner | 2015-06-30 18:45:33 | 1,632,652 0 | 1,632,652 | Form 4 |
| 7 | Advanced Technology Ventures VIII LP ATV Associates VIII L.L.C. 10% Owner | 2018-02-14 15:33:14 | 1,133,943 0 | 1,133,943 | Form 13G |
| 8 | Milne Jill C. CEO and President | 2025-03-25 16:07:38 | 761,000 0 | 761,000 | Form 4 |
| 9 | Matthews Andrea Chief Business Officer | 2025-03-25 16:07:11 | 262,500 0 | 262,500 | Form 4 |
| 10 | Harshbarger Benjamin Chief Legal Officer | 2025-03-25 16:06:17 | 262,500 0 | 262,500 | Form 4 |
| 11 | Clauser Noah Chief Financial Officer | 2025-03-25 16:05:43 | 262,500 0 | 262,500 | Form 4 |
| 12 | Morabito Christopher Chief Medical Officer | 2025-03-25 16:05:11 | 262,500 0 | 262,500 | Form 4 |
| 13 | Jirousek Michael Chief Scientific Officer | 2015-06-30 18:48:03 | 246,093 0 | 246,093 | Form 4 |
| 14 | Komjathy Andrew Chief Commercial Officer | 2025-03-25 16:06:49 | 225,000 0 | 225,000 | Form 4 |
| 15 | Hibben Edward K. Chief Business Officer | 2018-02-09 16:01:34 | 100,000 0 | 100,000 | Form 4 |
| 16 | Donovan Joanne M. CMO; SVP Clinical Development | 2020-02-14 15:00:22 | 60,000 0 | 60,000 | Form 4 |
| 17 | Nichols Andrew John Chief Scientific Officer | 2022-03-03 19:18:58 | 55,000 0 | 55,000 | Form 4 |
| 18 | Sanderson Ian C. Chief Financial Officer | 2016-02-16 18:27:42 | 52,000 0 | 52,000 | Form 4 |
| 19 | Modi Rick Chief Business Officer | 2016-09-13 17:24:54 | 45,000 0 | 45,000 | Form 4/A |
| 20 | Cunnane Deirdre A. Chief Legal Officer | 2019-02-15 08:42:34 | 40,000 0 | 40,000 | Form 4 |
| 21 | Callori Fred Director | 2025-06-12 17:51:39 | 26,550 0 | 26,550 | Form 4 |
| 22 | Beck Joanne T. Director | 2025-06-12 17:53:40 | 26,550 0 | 26,550 | Form 4 |
| 23 | Violin Jonathan Director | 2025-06-12 19:11:30 | 26,550 0 | 26,550 | Form 4 |
| 24 | LAPOINTE ANTHONY GREGG Director | 2025-06-12 19:12:31 | 26,550 0 | 26,550 | Form 4 |
| 25 | KISHBAUCH MICHAEL D Director | 2025-06-12 19:13:39 | 26,550 0 | 26,550 | Form 4 |
| 26 | Cole Hugh M Director | 2025-06-12 19:14:39 | 26,550 0 | 26,550 | Form 4 |
| 27 | BATE KENNETH Director | 2025-06-12 19:15:46 | 26,550 0 | 26,550 | Form 4 |
| 28 | AGARWAL SUNIL Director | 2025-06-12 19:16:46 | 26,550 0 | 26,550 | Form 4 |
| 29 | Ross Michael Jay Director | 2018-06-07 18:19:58 | 14,000 0 | 14,000 | Form 4 |
| 30 | George Jean Director | 2018-06-07 18:04:23 | 14,000 0 | 14,000 | Form 4 |
| 31 | ADELMAN BURT A Director | 2020-06-12 11:44:42 | 7,500 0 | 7,500 | Form 4 |
| 32 | GALAKATOS NICHOLAS Director | 2016-08-05 16:09:12 | 6,500 0 | 6,500 | Form 4 |